GSGaziza Azhmagievna Smagulova

Gaziza Azhmagievna Smagulova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gaziza Azhmagievna Smagulova has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PHARMACOECONOMIC AND CLINICAL ANALYSIS OF ORAL HYPOGLYCEMIC DRUG USE IN TYPE 2 DIABETES MELLITUS IN PRIMARY HEALTH CARE FACILITIES IN AKTOBE, KAZAKHSTAN

    by Indira Kaibagarova, Nurgul Ablakimova, Gaziza Smagulova, Nadiya Mavlyudova, Aigul Mussina, A.N. Ovsiannikova, A.SH. Sartayeva, Lazzat Zhamaliyeva

    Background. Type 2 diabetes mellitus remains one of the leading causes of chronic morbidity and disability, imposing a substantial clinical and economic burden on healthcare systems. In primary health care settings, effective glycemic control largely depends on the rational prescribing of oral hypoglycemic agents, appropriate dosing, and patient adherence to therapy. However, real-world clinical practice often demonstrates deviations of prescribed daily doses from recommended standards, along with persistent barriers related to drug accessibility and financial constraints. This highlights the need to analyze the structure of oral hypoglycemic drug utilization and the factors influencing the achievement of target glycemic outcomes. Aim:to analyze the consumption patterns and therapeutic effectiveness of oral hypoglycemic drugs (OHDs) among patients with T2DM in the primary healthcare system of Aktobe, Kazakhstan, while identifying indirect indicators and possible barriers to glycemic control based on prescription patterns and dosage data. Materials and methods: Data from 386 T2DM patients receiving continuous OHD therapy for at least six months were extracted from the Medical Information System. The analysis focused on drug consumption patterns, defined daily dose (DDD) versus prescribed daily dose (PDD), glycemic outcomes, and comorbidities. HbA1c levels were evaluated to assess treatment effectiveness, while factors influencing therapy adherence and dosing were explored. Results: Metformin was the most prescribed monotherapy (31.9%), and a combination of sulfonylureas and metformin dominated dual therapy (41.7%). Combination therapy was necessary for 59.1% of patients, indicating the limitations of monotherapy in con-trolling glycemia. Combination therapies involving metformin significantly improved HbA1c levels, especially with sulfonylureas (61%, p = 0.003) and SGLT-2 inhibitors (70.5%, p = 0.039). However, the PDDs of all OHDs were markedly below the WHO DDDs, with metformin's PDD 78% lower. Barriers included medication access and financial constraints. Conclusions: Optimizing OHD regimens and addressing medication access challenges are essential to improving glycemic control and reducing T2DM complications in resource-constrained environments. Актуальность: Сахарный диабет 2 типа остается одной из ведущих причин хронической заболеваемости и инвалидизации, формируя значительную клиническую и экономическую нагрузку на систему здравоохранения. В условиях первичной медико-санитарной помощи эффективность контроля гликемии во многом зависит от рационального назначения пероральных сахароснижающих препаратов, адекватности их дозирования и приверженности пациентов терапии. Однако в реальной клинической практике часто наблюдаются отклонения предписанных суточных доз от рекомендованных стандартов, а также сохраняются барьеры, связанные с доступностью лекарств и финансовыми ограничениями. Это определяет необходимость анализа структуры потребления ПССП и факторов, влияющих на достижение целевых показателей гликемии. Цель: Изучение структуры потребления и терапевтической эффективности пероральных сахароснижающих препаратов (ПССП) у пациентов с сахарным диабетом 2 типа (СД2) в системе первичной медико-санитарной помощи г. Актобе, Казахстан, а также выявление факторов, препятствующих достижению оптимального контроля гликемии. Методы: Из медицинской информационной системы были извлечены данные о 386 пациентах с СД2, получавших непрерывную терапию ПССП в течение не менее шести месяцев. Анализ был сосредоточен на структуре потребления лекарств, сравнении определенной суточной дозы (DDD) с предписанной суточной дозой (PDD), гликемических показателях и сопутствующих заболеваниях. Эффективность лечения оценивалась по уровню HbA1c, а также изучались факторы, влияющие на приверженность терапии и дозирование. Результаты:Метформин был наиболее часто назначаемым препаратом в монотерапии (31,9%), тогда как комбинация метформина с препаратами сульфонилмочевины преобладала в двойной терапии (41,7%). Комбинированная терапия применялась у 59,1% пациентов, что указывает на ограниченную эффективность монотерапии в контроле гликемии. Комбинированная терапия с использованием метформина значительно снижала уровень HbA1c, особенно при сочетании с...


  • Open Access

    MAPPING THE RESEARCH LANDSCAPE: IONIZING RADIATION-INDUCED OXIDATIVE STRESS AND INFLAMMATION IN THE BRAIN – A BIBLIOMETRIC ANALYSIS

    by M. Iztleuov, Ye. Iztleuov, G. Smagulova, S. Sakhanova, S. Saparbaev, N. Abugaliyeva

    Introduction: Ionizing radiation (IR) - induced oxidative stress and inflammation in the brain represent a significant global challenge, contributing to the molecular mechanisms underlying brain tissue damage and neurovascular disruption. Objective: This bibliometric analysis aims to evaluate the findings of studies investigating IR-induced oxidative stress and inflammation in the brain. Search Strategy: Utilizing the Scopus and Web of Science (WOS) databases, we analyzed 524 articles, including 404 research articles and 120 review articles. Results: Our results reveal a notable rise in research activity, reflecting increased awareness of this critical issue. The "International Journal of Radiation Biology" and the "International Journal of Molecular Sciences" emerged as the most prolific journals, playing pivotal roles in disseminating relevant findings. The United States, China, Egypt and India were identified as leading contributors, with institutions in Egypt and United States making significant impacts through high publication volumes. Kim J. and Tang F. emerged as notable authors in the field. Conclusions:Insights from this work are essential for shaping future research directions and enhancing our understanding of the underlying mechanisms, which are vital for developing protective and therapeutic strategies to mitigate radiation exposure's effects. Введение: Ионизирующее излучение (ИИ), индуцирующее окислительный стресс и воспаление в головном мозге, представляет собой значительную глобальную проблему, способствующую молекулярным механизмам повреждения мозговой ткани и нарушению нейроваскулярной функции. Цель: Данный библиометрический анализ направлен на оценку результатов исследований, посвящённых влиянию ИИ на развитие окислительного стресса и воспаления в мозге. Стратегия поиска: С использованием баз данных Scopus и Web of Science (WOS) было проанализировано 524 статьи, включая 404 оригинальных исследования и 120 обзорных статей. Результаты: Наши результаты выявили заметный рост исследовательской активности, что отражает возрастающее внимание к данной проблеме. Журналы International Journal of Radiation Biology и International Journal of Molecular Sciences оказались наиболее продуктивными и играют ключевую роль в распространении соответствующих научных данных. Соединённые Штаты, Китай, Египет и Индия определены как ведущие страны-участники, при этом учреждения Египта и США внесли значительный вклад благодаря высокому количеству публикаций. Среди авторов выделяются Kim J. и Tang F. Выводы: Полученные выводы имеют важное значение для формирования будущих направлений исследований и углубления понимания основных механизмов, что критически важно для разработки защитных и терапевтических стратегий по снижению последствий воздействия радиации. Кіріспе: Иондаушы сәулелену (ИС) - мида тотығу күйзелісі мен қабынуды тудырады, ми тінінің зақымдануы мен нейроваскулярлық бұзылыстардың молекулалық механизмдеріне ықпал ететін елеулі жаһандық мәселе болып табылады. Зерттеу мақсаты: Бұл библиометриялық талдау мида сәулеленудің әсерінен дамитын тотығу күйзелісі мен қабыну туралы зерттеген жұмыстардың нәтижелерін бағалауға бағытталған. Зерттеу әдістері: Scopus және Web of Science (WOS) деректер қорларын пайдалана отырып, барлығы 524 мақала талданды, оның ішінде 404 түпнұсқа зерттеу және 120 шолу мақалалары. Нәтижелері: Нәтижелер зерттеулер белсенділігінің айтарлықтай өскенін көрсетті, бұл мәселенің маңыздылығына деген назардың артқанын білдіреді. International Journal of Radiation Biology және International Journal of Molecular Sciences журналдары ең өнімді басылымдар ретінде анықталды және маңызды ғылыми деректерді таратуда жетекші рөл атқарады. АҚШ, Қытай, Египет және Үндістан жетекші елдер ретінде ерекшеленді, олардың ішінде Египет пен АҚШ мекемелері жоғары жарияланымдарымен айтарлықтай үлес қосты. Авторлар арасында Kim J. және Tang F. ең белсенді зерттеушілер ретінде аталды. Қорытынды: Бұл жұмыстың нәтижелері болашақ...

  • Open Access

    Next-generation sequencing and bioinformatics analysis in breast cancer research: Insights from Western Kazakhstan

    by Marzhan Aitmagambetova, Nazar Seidalin, Dmitriy Babenko, Gaziza Smagulova, Saule Balmagambetova, Arip Koishybaev, Anar Tulyayeva, Nurgul Kereyeva, Dinara Zholmukhamedova, Azamat Zharylgapov, et al.

    Breast cancer (BC) is one of the most prevalent malignancies among women worldwide and a leading cause of cancer-related mortality. Studying gene mutations associated with BC risk in Kazakh women can help identify hereditary predispositions and facilitate early prevention. Next-generation sequencing (NGS) technology was used to sequence 113 candidate genes, followed by bioinformatics analysis, on BC patients from Western Kazakhstan. NGS sequencing revealed 28 polymorphisms from the genome-wide association studies catalog, seven of which were identified as statistically significant risk polymorphisms for BC: RARG (Rs2229774), FGFR2 (Rs2981582), ATM (Rs1800057), MAP3K1 (Rs889312), BRCA2 (Rs11571833), FGFR2 (Rs7895676), and FGFR2 (Rs1219648). Inheritance model analysis showed that the polymorphism in the Rs2981582 of the FGFR2 gene increased the likelihood of developing BC across four inheritance models. The Rs2229774 polymorphism of the RARG gene elevated BC risk in three models, whereas the Rs889312 polymorphism of the MAP3K1 gene did so in two models. The Rs137852985 polymorphism of the BRIP1 gene raised BC risk in four models, and Rs137852576 of the AR gene increased the risk in the codominant model. In a one-factor risk prediction, 32 significant factors were identified, with risks ranging from 69.7% to 90.6%. The combination of polymorphisms “Rs2229774 (AG),” “Rs889312 (AA, CC),” and “Age <54 years” yielded a high-risk assessment (95.8%), with a predictive quality score of 0.88. Overall, NGS sequencing identified six statistically significant gene polymorphisms (ATM Rs1800057, RARG Rs2229774, BRCA2 Rs11571833, MAP3K1 Rs889312, FGFR2 Rs2981582, and BRIP1 Rs137852985) associated with a high risk of BC in Kazakh women.

  • MYOEPITHELIAL CARCINOMA OF SOFT TISSUES OF THE RIGHT AXILLARY REGION WITH METASTASIS TO THE CECUM: A CLINICAL CASE

    by M. Aitmagambetova, A. Koishybaev, G. Smagulova, A. Zhumasheva, N. Kereeva, A. Tulyaeva, D. Koishybaeva, A. Zharylgapov, N. Imanbaev, G. Bakytzhanov, et al.

    Relevance: Myoepithelial carcinoma is a morphologically diverse tumor that arises either de novo or due to the malignant transformation of its benign counterpart, myoepithelium. These are relatively lesser-known lesions rarely found in the head and neck area. Myoepithelial carcinoma (MC) is a rare malignancy primarily found in the salivary gland. MK can be confused with many other tumors outside the salivary glands, as a wide range of cytomorphological and immunohistochemical features characterizes them. Soft tissue MCs are extremely rare, although a salivary gland MC is relatively common and well-known with similar morphology. The histogenesis of soft tissue MC is still unknown. The tumor may have myoepithelial differentiation but is not derived from myoepithelial cells. Due to the rarity of soft tissue MCs, the number of studies and data on this tumor’s clinical and pathological characteristics are limited. In addition, the limited number of diagnostic criteria and prognostic parameters makes diagnosing and treating soft tissue MC difficult. The article describes a rare case of MC, formed from the soft tissues of the axillary region, with metastasis to the cecum. The purpose was to describe the imaging and clinicopathological features of axillary myoepithelial carcinoma of soft tissues with metastasis to the cecum and to form an understanding of this disease. Methods: A rare case of soft tissue CM of the axillary region with metastasis to the cecum is described. A 57-year-old woman complained of lymphadenopathy in the right axillary region in October 2020. Results: According to ultrasound examination, the lymph node is up to 3.0x3.5 cm in the right axillary region. Based on histopathological and immunohistochemical (IHC) data, on 02/03/2022, the final diagnosis was made: MK of the soft tissues of the right axillary region. According to positron emission tomography/computed tomography (PET/CT), after 4 months, a local focus of active accumulation was detected in the projection of the cecum, with an adjacent enlarged regional lymph node of the paracolic group. On January 18, 2023, surgical treatment was performed in the following volume: “Right-sided hemicolectomy.” Histological examination confirmed MC. According to the multidisciplinary team’s (MDG) decision, the patient received 3 courses of targeted therapy. Conclusion: This case report raises awareness and improves MC diagnostics and treatment.


  • Open Access

    Comprehensive pharmacoepidemiological and clinical-economic analysis of antibacterial drugs consumed during the pandemic at the hospital level in Aktobe, Kazakhstan

    by Aigerim Aldiyarovna Balapasheva, Aigul Zakarievna Mussina, Gaziza Azhmagievna Smagulova, Liliya Evgenievna Ziganshina

    Aim: The study aimed to analyze the frequency and structure of antibacterial drug consumption during the COVID-19 pandemic at a dispensary hospital in Aktobe, Kazakhstan. It sought to identify the most frequently used and most costly antibacterial drugs, assessing their economic impact and usage patterns. Methods: This descriptive, retrospective clinical, economic, and pharmacoepidemiological study was conducted using data from the dispensary hospital's pharmacy and patient records between March 13, 2020, and December 31, 2020. The ABC/VEN analysis and ATC/DDD methodology were applied to evaluate the consumption of antibacterial drugs. Antibiotics were classified according to WHO AWARe criteria. Results: The study found that 27 different antibacterial drugs were used, representing 2.2% of all medications. The ABC/VEN analysis revealed that the majority of the budget was spent on a few high-cost drugs. Ceftriaxone was the most commonly used antibiotic, with a significant financial impact. According to the WHO AWaRe classification, most antibiotics fell into the Access and Watch categories. Conclusion: The study highlights a high rate of antibacterial drug usage, with significant financial implications for the hospital. The predominance of certain high-cost antibiotics, like ceftriaxone, indicates a need for more rational and cost-effective use of these medications. The findings call for improved adherence to clinical guidelines, enhanced education for medical professionals, and optimized antibiotic utilization to prevent resistance development and ensure better patient outcomes, especially in pandemic situations.


  • Open Access

    Pharmacoepidemiological Analysis of Antibacterial Agents Used in a Provisional Hospital in Aktobe, Kazakhstan, in the Context of COVID-19: A Comparison with the Pre-Pandemic Period

    by Aigerim A. Balapasheva, Gaziza A. Smagulova, Aigul Z. Mussina, Liliya E. Ziganshina, Zhansulu Zh. Nurgaliyeva

    In the context of the global spread of Coronavirus Disease 2019 (COVID-19), the issue of evaluating and optimizing the use of antibacterial drugs becomes especially relevant. The coronavirus pandemic has provided a unique opportunity to study the dynamics of the consumption of antibacterial agents and their impact on public health. The rational use of antibiotics is a key aspect of the fight against antimicrobial resistance, which makes this study particularly important. The aim of this study was to assess changes in the consumption of antibacterial drugs among patients hospitalized with COVID-19 during the peak of the 2020 pandemic and compare them with data from 2019 prior to the pandemic. This study collated data on antibacterial drug consumption in a regional hospital in Aktobe, which served a large population of patients during the pandemic. A pharmacoepidemiological study was conducted using the Anatomical Therapeutic Chemical (ATC)/Defined Daily Dose (DDD) methodology. The pharmacoepidemiological study using the international ATC/DDD methodology revealed a concerning pattern of irrational consumption of antibacterial drugs, including cephalosporins, azalides, second-generation fluoroquinolones, and systemic aminoglycosides in Aktobe. Among antibacterial drugs during the pandemic, the most significant increase in consumption was from the group of cephalosporins (19,043 DDD/100 bed-days). The share of their consumption was 35.4% of the total consumption of antibacterial drugs. Pharmacoepidemiological studies using the international methodology ATC/DDD showed an alarming picture of irrational consumption of antibacterial drugs of the group of cephalosporins, azalides, fluoroquinolones, and aminoglycosides in Aktobe, and, in this case, excessive use of the identified antibiotics raises concerns about the possibility of increasing the problem of resistance to microbes.


  • Open Access

    Bibliometric Analysis of Global Research Output on Antimicrobial Resistance among Pneumonia Pathogens (2013–2023)

    by Nurgul Ablakimova, Gaziza A. Smagulova, Svetlana Rachina, Aigul Z. Mussina, Afshin Zare, Nadiar M. Mussin, Asset A. Kaliyev, Reza Shirazi, Nader Tanideh, Amin Tamadon

    Antimicrobial resistance (AMR) is a pressing global concern, posing significant challenges to the effective treatment of infections, including pneumonia. This bibliometric analysis aims to investigate the research output on AMR among pneumonia pathogens from 2013 to 2023. Data were extracted from the Web of Science Core Collection (WOS-CC) using an inclusive search strategy. The analysis included 152 relevant studies published in 99 different sources, involving 988 authors and yielding an average of 16.33 citations per document over the past decade. The findings reveal a notable increase in research on AMR among pneumonia pathogens, indicating a growing awareness of this critical issue. Collaborative studies were prevalent, with the majority of authors engaging in joint research efforts. Bradford’s Law identified twelve core journals that were instrumental in disseminating research in this field, with “Medicine” emerging as the most prolific journal. The USA and China emerged as the leading contributors, while Germany displayed a strong inclination towards collaborative research. Intermountain Medical Center, Saitama Medical University, and Udice-French Research Universities were the most productive institutions, and Yayan J. and Rasche K. were the top authors. Furthermore, the analysis identified commonly encountered microorganisms such as Acinetobacter baumanii and Klebsiella pneumoniae in the context of AMR. Time-based analysis of keywords highlighted the significance of terms like “community-acquired pneumonia” and “ventilator-associated pneumonia”. Overall, this comprehensive study sheds light on the global research landscape of AMR among pneumonia pathogens. The insights gained from this analysis are essential for guiding future research priorities and collaborative efforts to combat AMR effectively and improve treatment outcomes for pneumonia and related infections. As the frequency of reports concerning resistance among pneumonia pathogens, notably A. baumannii and K. pneumoniae, continues to rise, there is an immediate requirement for pharmaceutical manufacturers and healthcare providers to respond proactively and ready themselves for the forthcoming implications of this matter. It also underscores the importance of knowledge dissemination and evidence-based interventions to address this growing public health challenge. However, the study acknowledges the limitations associated with using a single publication database and encourages the inclusion of data from other sources in future research.


  • Open Access

    Microbial Landscape and Antibiotic-Susceptibility Profiles of Microorganisms in Patients with Bacterial Pneumonia: A Comparative Cross-Sectional Study of COVID-19 and Non-COVID-19 Cases in Aktobe, Kazakhstan

    by Nurgul Ablakimova, Aigul Z. Mussina, Gaziza A. Smagulova, Svetlana Rachina, Meirambek S. Kurmangazin, Aigerim Balapasheva, Dinara Karimoldayeva, Afshin Zare, Mahdi Mahdipour, Farhad Rahmanifar

    This cross-sectional study investigated the microbial landscape and antibiotic-resistance patterns in patients with bacterial pneumonia, with a focus on the impact of COVID-19. Sputum samples from individuals with bacterial pneumonia, including coronavirus disease 2019-positive polymerase chain reaction (COVID-19-PCR+), COVID-19-PCR− and non-COVID-19 patients, were analyzed. Surprisingly, the classic etiological factor of bacterial pneumonia, Streptococcus pneumoniae, was rarely isolated from the sputum samples. Furthermore, the frequency of multidrug-resistant pathogens was found to be higher in non-COVID-19 patients, highlighting the potential impact of the pandemic on antimicrobial resistance. Strains obtained from COVID-19-PCR+ patients exhibited significant resistance to commonly used antibiotics, including fluoroquinolones and cephalosporins. Notably, the ESKAPE pathogens, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterobacter cloacae, and Enterobacter aerogenes, were identified among the isolated microorganisms. Our findings underscore the urgent need for infection control measures and responsible antibiotic use in healthcare settings, as well as the importance of enhancing pneumonia diagnostics and implementing standardized laboratory protocols.


  • QUANTIFICATION OF DNA DOUBLE-STRAND BREAKS IN BENIGN AND MALIGNANT BREAST DISEASES

    by G. Smagulova, M. Aitmagambetova, G. Veklenko, N. Kereeva, A. Zheksenova, A. Amanzholkyz, A. Tulyaeva, G. Bakytzhanov

    Relevance: Double-strand DNA breaks are the most dangerous DNA damage. Analysis of foci of phosphorylated histone protein H2AX (γH2AX) is currently the most sensitive method for detecting DNA double-strand breaks. This protein modification can become a biomarker of cellular stress, especially in diagnosing and monitoring neoplastic diseases. In this study, we utilized novel pattern recognition algorithms on the AKLIDES® platform to automatically analyze immunofluorescent images of γH2AX foci and compare the results with visual scores. The γH2AX foci formation on peripheral blood mononuclear cells of women with breast cancer or benign breast tumors was studied. The article aimed to quantify DNA double-strand breaks in peripheral blood lymphocytes in women with breast cancer and benign breast masses to identify a possible biomarker. Methods: γ-H2AX foci in lymphocytes were analyzed using the automated AKLIDES system in patients with breast cancer (n=29) and benign breast tumors (n=24). Results: When comparing the indicators of the main and control groups in the channel of ruptures “FITC,” a statistically significant difference was found in the indicators “Foci dia” (p=0.0382), “Focilnt mean” (p=0.0166), “Colocalisation” (p=0.0486). In the repair channel “AРС,” significant differences were found in the indicators “Nuclei BGInt” (p=0.0166) and the indicator “Focilnt mean” (p=0.0118). Conclusion: The revealed changes of DNA double-strand breaks along the FITC break channels and APC repair between the main and control groups can possibly serve as a breast cancer diagnostic marker.

  • QUANTIFICATION OF DNA DOUBLE-STRAND BREAKS IN BENIGN AND MALIGNANT BREAST DISEASES

    by G. Smagulova, M. Aitmagambetova, G.V. Veklenko, N. Kereeva, A. Zheksenova, A. Amanzholkyz, A. Tulyaeva, G. Bakytzhanov

    Relevance: Double-strand DNA breaks are the most dangerous DNA damage. Analysis of foci of phosphorylated histone protein H2AX (γH2AX) is currently the most sensitive method for detecting DNA double-strand breaks. This protein modification can become a biomarker of cellular stress, especially in diagnosing and monitoring neoplastic diseases. In this study, we utilized novel pattern recognition algorithms on the AKLIDES® platform to automatically analyze immunofluorescent images of γH2AX foci and compare the results with visual scores. The γH2AX foci formation on peripheral blood mononuclear cells of women with breast cancer or benign breast tumors was studied. The article aimed to quantify DNA double-strand breaks in peripheral blood lymphocytes in women with breast cancer and benign breast masses to identify a possible biomarker. Methods: γ-H2AX foci in lymphocytes were analyzed using the automated AKLIDES system in patients with breast cancer (n=29) and benign breast tumors (n=24). Results: When comparing the indicators of the main and control groups in the channel of ruptures “FITC,” a statistically significant difference was found in the indicators “Foci dia” (p=0.0382), “Focilnt mean” (p=0.0166), “Colocalisation” (p=0.0486). In the repair channel “AРС,” significant differences were found in the indicators “Nuclei BGInt” (p=0.0166) and the indicator “Focilnt mean” (p=0.0118). Conclusion: The revealed changes of DNA double-strand breaks along the FITC break channels and APC repair between the main and control groups can possibly serve as a breast cancer diagnostic marker.